Cargando…
Peripheral B‐cell dysregulation is associated with relapse after long‐term quiescence in patients with multiple sclerosis
B cells play a major role in multiple sclerosis (MS), with many successful therapeutics capable of removing them from circulation. One such therapy, alemtuzumab, is thought to reset the immune system without the need for ongoing therapy in a proportion of patients. The exact cells contributing to di...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322415/ https://www.ncbi.nlm.nih.gov/pubmed/35416319 http://dx.doi.org/10.1111/imcb.12552 |